Biocon Management

Management criteria checks 4/4

Biocon's CEO is Siddharth Mittal, appointed in Dec 2019, has a tenure of 4.92 years. total yearly compensation is ₹57.31M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.069% of the company’s shares, worth ₹275.38M. The average tenure of the management team and the board of directors is 2.3 years and 3 years respectively.

Key information

Siddharth Mittal

Chief executive officer

₹57.3m

Total compensation

CEO salary percentage100.0%
CEO tenure4.9yrs
CEO ownership0.07%
Management average tenure2.3yrs
Board average tenure3yrs

Recent management updates

Recent updates

Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results

Nov 02
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results

Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E

Nov 01
Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E

Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?

Oct 14
Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?

These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Sep 20
These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors

Jun 29
Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors

Is Biocon (NSE:BIOCON) A Risky Investment?

Jun 11
Is Biocon (NSE:BIOCON) A Risky Investment?

Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50

Jun 11
Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50

Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations

May 24
Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations

Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50

May 23
Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50

Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?

Mar 20
Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?

Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next

Feb 12
Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next

Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price

Jan 23
Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price

Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price

Jan 03
Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price

These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Nov 13
These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)

Aug 03
Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)

Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50

Jul 03
Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50

Is Biocon (NSE:BIOCON) Using Too Much Debt?

Jul 02
Is Biocon (NSE:BIOCON) Using Too Much Debt?

Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50

May 26
Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50

Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)

Mar 28
Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)

Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly

Feb 26
Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly

Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate

Dec 17
Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate

Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?

Sep 05
Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?

Is Biocon (NSE:BIOCON) Using Too Much Debt?

Jul 13
Is Biocon (NSE:BIOCON) Using Too Much Debt?

Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate

May 26
Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate

CEO Compensation Analysis

How has Siddharth Mittal's remuneration changed compared to Biocon's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹14b

Jun 30 2024n/an/a

₹16b

Mar 31 2024₹57m₹57m

₹10b

Dec 31 2023n/an/a

₹12b

Sep 30 2023n/an/a

₹5b

Jun 30 2023n/an/a

₹4b

Mar 31 2023₹48m₹48m

₹5b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹6b

Jun 30 2022n/an/a

₹7b

Mar 31 2022₹42m₹42m

₹6b

Dec 31 2021n/an/a

₹7b

Sep 30 2021n/an/a

₹7b

Jun 30 2021n/an/a

₹7b

Mar 31 2021₹43m₹43m

₹7b

Dec 31 2020n/an/a

₹6b

Sep 30 2020n/an/a

₹6b

Jun 30 2020n/an/a

₹7b

Mar 31 2020₹49m₹31m

₹8b

Compensation vs Market: Siddharth's total compensation ($USD678.67K) is about average for companies of similar size in the Indian market ($USD590.37K).

Compensation vs Earnings: Siddharth's compensation has been consistent with company performance over the past year.


CEO

Siddharth Mittal (46 yo)

4.9yrs

Tenure

₹57,310,000

Compensation

Mr. Siddharth Mittal, BCom, CA, CPA has been CEO and Director of Biocon Limited since December 1, 2019. He has been Managing Director of Biocon Limited since April 01, 2020 and served as its Joint Managing...


Leadership Team

NamePositionTenureCompensationOwnership
Kiran Mazumdar-Shaw
Founder & Executive Chairperson46yrs₹38.43m40.49%
₹ 160.6b
Siddharth Mittal
MD, CEO & Director4.9yrs₹57.31m0.069%
₹ 275.4m
Peter James Bains
Group Chief Executive Officer1.2yrs₹1.91mno data
Mukesh Kamath
Chief Financial Officerless than a yearno datano data
Arun Gupta
Head of Operations1.6yrsno datano data
Atanu Roy
Group Chief Information Officer4.2yrsno datano data
Saurabh Paliwal
Head of Investor Relations2.3yrsno datano data
Mayank Verma
Company Secretary & Compliance Officer5.3yrs₹5.75mno data
Seema Ahuja
Global Head of Communications & Corporate Brandno datano datano data
Maninder Puri
Head of Human Resourcesno datano datano data
Paul Thomas
Chief Commercial Officerno datano datano data
Abhijit Zutshi
Commercial Head of Biocon Global Genericsno datano data0.019%
₹ 73.6m

2.3yrs

Average Tenure

54.5yo

Average Age

Experienced Management: BIOCON's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kiran Mazumdar-Shaw
Founder & Executive Chairperson46yrs₹38.43m40.49%
₹ 160.6b
Siddharth Mittal
MD, CEO & Director4.9yrs₹57.31m0.069%
₹ 275.4m
Ravi Mazumdar
Non-Executive Non-Independent Director24.3yrs₹6.23m0.44%
₹ 1.8b
Bobby Parikh
Independent Non-Executive Director6.3yrs₹7.81mno data
Naina Lal Kidwai
Additional Non-Executive Independent Director2.6yrs₹6.24mno data
Satish Garg
Member of Scientific Advisory Boardno datano datano data
Nicholas Haggar
Independent Directorless than a year₹5.20mno data
Shashank Joshi
Member of Scientific Advisory Boardno datano datano data
Rekha Menon
Independent Director1.3yrs₹5.70mno data
Eric Mazumdar
Non-Executive Director3yrs₹5.57m0.27%
₹ 1.1b
John Petrie
Member of Scientific Advisory Boardno datano datano data
Atul Dhawan
Non-Executive and Independent Directorless than a yearno datano data

3.0yrs

Average Tenure

62.5yo

Average Age

Experienced Board: BIOCON's board of directors are considered experienced (3 years average tenure).